INS and morbid obesity: Consequently, the emerging view is that, as in several other inflammatory conditions, during morbid obesity non-neuronal cholinergic systems become activated and exert beneficial depot-specific effects on distinctive pathophysiological aspects of morbid obesity; these aspects may range from reduction of WAT inflammation and insulin resistance to increase of brown fat-mediated energy expenditure.